For breast cancer patients with liver metastases, if the patient was found to have “primary” liver cancer before surgery, FMI-guided surgery using the HER2 probe will identify the true primary tumour in the breast during surgery and increase the precision of cancer surgery. The gene discussed is ERBB2; the disease is neoplasm.